Review
doi: 10.1007/BF01411552.
The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy
Affiliations
- PMID: 9442212
- DOI: 10.1007/BF01411552
Item in Clipboard
Review
The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy
Acta Neurochir (Wien).
1997.
Abstract
The present article reviews the role of the second messenger enzyme protein kinase C (PKC) in the growth regulation of high-grade gliomas, and evaluates the efficacy of therapeutic strategies directed against PKC for blocking the proliferation of these malignancies in in vitro and in vivo models. The translation of such strategies to the treatment of patients with malignant gliomas may provide a novel approach for improving the otherwise grim outlook associated with these neoplasms.
Similar articles
-
Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas?Oncologist. 2002;7(1):17-33. doi: 10.1634/theoncologist.7-1-17. Oncologist. 2002. PMID: 11854544 Review.
-
Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor.J Neurosurg. 1996 Jun;84(6):1024-32. doi: 10.3171/jns.1996.84.6.1024. J Neurosurg. 1996. PMID: 8847567
-
Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C.Neurosurgery. 1992 Oct;31(4):717-24; discussion 724. doi: 10.1227/00006123-199210000-00015. Neurosurgery. 1992. PMID: 1407458
-
The effect of calphostin C, a potent photodependent protein kinase C inhibitor, on the proliferation of glioma cells in vitro.J Neurooncol. 1997 Feb;31(3):255-66. doi: 10.1023/a:1005729626354. J Neurooncol. 1997. PMID: 9049854
-
Application of signal transduction inhibition as a therapeutic strategy for central nervous system tumors.Pediatr Neurosurg. 1998 Nov;29(5):228-44. doi: 10.1159/000028729. Pediatr Neurosurg. 1998. PMID: 9917540 Review.
Cited by
-
Semi-Synthetic Ingenol Derivative from Euphorbia tirucalli Inhibits Protein Kinase C Isotypes and Promotes Autophagy and S-phase Arrest on Glioma Cell Lines.Molecules. 2019 Nov 22;24(23):4265. doi: 10.3390/molecules24234265. Molecules. 2019. PMID: 31771098 Free PMC article.
-
Transactivation of the epidermal growth factor receptor by heat shock protein 90 via Toll-like receptor 4 contributes to the migration of glioblastoma cells.J Biol Chem. 2011 Feb 4;286(5):3418-28. doi: 10.1074/jbc.M110.154823. Epub 2010 Dec 2. J Biol Chem. 2011. PMID: 21127066 Free PMC article.
-
Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade.J Neurochem. 2000 Feb;74(2):564-73. doi: 10.1046/j.1471-4159.2000.740564.x. J Neurochem. 2000. PMID: 10646507 Free PMC article.
-
Phorbol 12-myristate 13-acetate induces epidermal growth factor receptor transactivation via protein kinase Cdelta/c-Src pathways in glioblastoma cells.J Biol Chem. 2005 Mar 4;280(9):7729-38. doi: 10.1074/jbc.M409056200. Epub 2004 Dec 23. J Biol Chem. 2005. PMID: 15618223 Free PMC article.
-
Staurosporine-induced growth inhibition of glioma cells is accompanied by altered expression of cyclins, CDKs and CDK inhibitors.Neurochem Res. 2006 May;31(5):685-92. doi: 10.1007/s11064-006-9068-0. Epub 2006 May 23. Neurochem Res. 2006. PMID: 16770740
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical